In early use, trastuzumab is approved for use following standard (adjuvant) chemotherapy.
在早期使用中，曲妥珠单抗可作为以后的标准化化疗药物。
They also found that this synergy occurred with trastuzumab and either paclitaxel or vincristine.
他们发现这种协同作用也发生在脂质体和长春新碱或紫杉醇。
HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer.
HER2的异质性会影响HER 2阳性转移性乳腺癌患者曲妥珠单抗的效果和生存期。
We analyzed the sensibility, specificity, positive and negative predictive values of the SELDI-TOF-MS trastuzumab resistance standard.
分析该蛋白界定标准评判曲妥珠单抗耐药的灵敏度、特异度以及阳性预测值、阴性预测值。
Trastuzumab is a humanised antibody, designed to target and block the function of HER2, a protein produced by a specific gene with cancer-causing potential.
曲妥珠单抗是一种人源化抗体，用于靶向和阻断her2的功能，而后者是由特异基因编码的一种蛋白，具有致癌潜能。
We investigated the impact of HER2 heterogeneity on trastuzumab responses and clinical outcomes in 112 patients with HER2-positive metastatic breast cancer.
我们调查了HER 2异质性对112例her 2阳性转移性乳腺癌患者的曲妥珠单抗疗效和临床预后的影响。
Like most treatments, trastuzumab is associated with side-effects, the most common of which are mild flu-like symptoms, such as chills and fever during its administration.
和大多数治疗一样，曲妥珠单抗也有副作用，最常见的是轻度流感样症状，如寒战和发热。
Like most treatments, trastuzumab is associated with side-effects, the most common of which are mild flu-like symptoms, such as chills and fever during its administration.
和大多数治疗一样，曲妥珠单抗也有副作用，最常见的是轻度流感样症状，如寒战和发热。
应用推荐